Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Certara (CERT), a leader in model-informed drug development, has announced its participation in the upcoming 43rd Annual J.P. Morgan Healthcare Conference. The company's management team is scheduled to present on Wednesday, January 15th, 2025, at 5:15 PM Pacific Time.
Investors and interested parties can access a live webcast of the presentation through Certara's investor relations website at https://ir.certara.com. The presentation recording will remain available for replay on the website for a minimum of 30 days following the event.
Positive
- None.
Negative
- None.
News Market Reaction – CERT
In the trading session that priced this news, CERT gained 5.16%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
RADNOR, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the 43rd Annual J.P. Morgan Healthcare Conference.
Company management will present at 5:15PM PT on Wednesday, January 15th, 2025.
A live webcast of the event will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 30 days thereafter.
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com
